Ditchcarbon
  • Customers
  1. Organizations
  2. Geron Corporation
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

Geron Corporation

Company website

Geron Corporation, a pioneering biotechnology firm headquartered in the United States, focuses on developing innovative therapies for cancer and other serious diseases. Founded in 1990, Geron has made significant strides in the field of telomerase biology, positioning itself as a leader in the development of telomerase inhibitors. The company’s flagship product, imetelstat, is a first-in-class telomerase inhibitor that targets cancer stem cells, offering a unique approach to treating various malignancies. Geron’s commitment to advancing cancer treatment has garnered attention within the industry, as it continues to explore new therapeutic avenues and expand its operational reach. With a strong emphasis on research and development, Geron Corporation remains at the forefront of biopharmaceutical innovation, striving to improve patient outcomes in oncology.

DitchCarbon Score

How does Geron Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Geron Corporation's score of 25 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

30%

Let us know if this data was useful to you

Geron Corporation's reported carbon emissions

Geron Corporation, headquartered in the US, currently does not have available carbon emissions data for the most recent year, as indicated by the absence of specific figures. Consequently, there are no reported emissions in kg CO2e, nor are there any documented reduction targets or climate pledges. As of now, Geron Corporation has not established any Science-Based Targets Initiative (SBTi) reduction targets or other significant climate commitments. The company does not inherit emissions data from a parent organisation, indicating that its climate strategy is independently developed. In the context of the industry, it is essential for companies like Geron Corporation to actively engage in climate initiatives and set measurable targets to contribute to global emissions reduction efforts. Without specific data or commitments, the company's current climate impact remains unclear.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Geron Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Geron Corporation is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Geron Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

CRISPR Therapeutics AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Tissue Genesis, Inc.

US
•
Research and development services (73)
Updated 13 days ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Emmaus Life Sciences, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

BioRestorative Therapies, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250807.8
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy